After a rigorous selection process, the Desjardins Group Board of Directors is pleased to announce that Denis Dubois has been appointed as President and CEO. He will step into this role on September 2 ...

Gateway Fleets, the electrification platform purpose-built for last-mile delivery, today announced the opening of its newest electric vehicle charging depot in Riverside, California. Built in just ...

Organon was then acquired by Schering-Plough ... another area that has been poorly served by the pharma R&D investment model as returns on such drugs are usually low. Catriona Crombie, fund ...

Story April 9 - Organon: The women’s health drugmaker ... Novartis is making to its cardiovascular commercialization model that are designed to “simplify and strengthen” how the drugmaker ...

INCHEON, Korea & JERSEY CITY, N.J., May 27, 2025--Organon and Samsung Bioepis' HADLIMA granted FDA interchangeability designation approval for all high- and-low concentration presentations.

More Bonds of Organon & Co./ Organon Foreign Debt Co-Issuer B.V. About the Organon & Co./ Organon Foreign Debt Co-Issuer B.V.-Bond (USU6835WAB01) The Organon & Co./ Organon Foreign Debt Co-Issuer ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The AI model showed high accuracy in detecting body parts and eczema areas, with strong correlation to physician assessments. Weak correlation between AI severity scores and patient-reported itch ...

Marktkapitalisierung - Misst den gesamten Eigenkapitalwert eines börsennotierten Unternehmens, wie er durch den letzten beobachteten Handelskurs der Aktie impliziert wird. Im Falle von Kryptowährungen ...

Using social media as a pharma brand can feel risky due to regulatory constraints - but it can make a big impact when used in ...